SAN DIEGO–(BUSINESS WIRE)—- $TVTX–Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that it will share nine new data presentations, including five oral presentations, at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, CO, October 21-25. The presentations highlight compelling new data on FILSPARI® (sparsentan) in patients with IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS).”The final SPARTAN analysis provides a compelling picture of what’s possible whe
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
